Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat

Author： Kuzumoto Y. Kusunoki S. Kato N. Kihara M. Low P.

ISSN： 0012-186X

Source： Diabetologia, Vol.49, Iss.12, 2006-12, pp. : 3085-3093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

By Hamada Yoji Nakamura Jiro

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 245-255

Adis International

Access to resources Recommend Favorite

Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-09 ,pp. : 234-240

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy

By Li F. Szabó C. Pacher P. Southan G. Abatan O. Charniauskaya T. Stevens M. Obrosova I.

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 710-717

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor

By Calcutt N. Freshwater J. Mizisin A.

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 718-724

Springer Publishing Company

Access to resources Recommend Favorite

Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency

By Ii S. Ohta M. Kudo E. Yamaoka T. Tachikawa T. Moritani M. Itakura M. Yoshimoto K.

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 541-548

Springer Publishing Company

Access to resources Recommend Favorite